We are live on ! Find out more
AL

Aspiriant LLC Portfolio holdings

AUM $4.05B
1-Year Est. Return 19.01%
This Fund
S&P 500
This Quarter Est. Return
-1.34%
1 Year Est. Return
+19.01%
3 Year Est. Return
+47.13%
5 Year Est. Return
+48.95%
10 Year Est. Return
+147.53%
AUM
$2.77B
AUM Growth
+$134M
Cap. Flow
+$184M
Cap. Flow %
6.65%
Top 10 Hldgs %
66.52%
Holding
311
New
19
Increased
124
Reduced
101
Closed
23

Sector Composition

Rank Sector Weight
1 Technology 4.54%
2 Financials 2.48%
3 Communication Services 1.28%
4 Consumer Discretionary 0.73%
5 Healthcare 0.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWD icon
51
iShares Russell 1000 Value ETF
IWD
$81.5B
$6.26M 0.23%
33,800
-923
-3% -$177K
SCHX icon
52
Schwab US Large- Cap ETF
SCHX
$71.1B
$5.91M 0.21%
254,914
-2,072
-0.8% -$48.3K
VOTE icon
53
TCW Transform 500 ETF
VOTE
$1.09B
$5.79M 0.21%
84,135
+23,642
+39% +$1.63M
QAI icon
54
NYLI Hedge Multi-Strategy Tracker ETF
QAI
$1.01B
$5.75M 0.21%
183,058
-11,474
-6% -$370K
PG icon
55
Procter & Gamble
PG
$346B
$5.55M 0.2%
33,076
+2,510
+8% +$427K
VUG icon
56
Vanguard Growth ETF
VUG
$216B
$5.38M 0.19%
78,624
-7,380
-9% -$496K
BILL icon
57
BILL Holdings
BILL
$4.47B
$5.05M 0.18%
59,594
-2,511
-4% -$187K
VWO icon
58
Vanguard FTSE Emerging Markets ETF
VWO
$120B
$4.86M 0.18%
110,423
+7,744
+8% +$360K
CINF icon
59
Cincinnati Financial
CINF
$28.5B
$4.77M 0.17%
33,214
IYY icon
60
iShares Dow Jones US ETF
IYY
$2.93B
$4.26M 0.15%
29,744
EFA icon
61
iShares MSCI EAFE ETF
EFA
$76.8B
$4.15M 0.15%
54,843
+7,313
+15% +$579K
IJH icon
62
iShares Core S&P Mid-Cap ETF
IJH
$123B
$4.03M 0.15%
64,652
-1,054
-2% -$67.6K
IWF icon
63
iShares Russell 1000 Growth ETF
IWF
$120B
$3.97M 0.14%
39,532
+564
+1% +$55.5K
IUSG icon
64
iShares Core S&P US Growth ETF
IUSG
$31.1B
$3.87M 0.14%
27,787
RSP icon
65
Invesco S&P 500 Equal Weight ETF
RSP
$97.1B
$3.73M 0.13%
21,296
-1,042
-5% -$188K
RY icon
66
Royal Bank of Canada
RY
$291B
$3.71M 0.13%
30,756
+48
+0.2% +$5.92K
MNA icon
67
IQ ARB Merger Arbitrage ETF
MNA
$252M
$3.51M 0.13%
106,537
-11,222
-10% -$369K
SDG icon
68
iShares MSCI Global Sustainable Development Goals ETF
SDG
$168M
$3.49M 0.13%
48,797
+23,053
+90% +$1.8M
IWR icon
69
iShares Russell Mid-Cap ETF
IWR
$56.1B
$3.49M 0.13%
39,454
+3,075
+8% +$279K
SCZ icon
70
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.3B
$3.48M 0.13%
57,260
+71
+0.1% +$4.52K
VNQ icon
71
Vanguard Real Estate ETF
VNQ
$39.8B
$3.41M 0.12%
38,281
-1,614
-4% -$153K
ORCL icon
72
Oracle
ORCL
$345B
$3.29M 0.12%
19,761
-228
-1% -$40.5K
VONV icon
73
Vanguard Russell 1000 Value ETF
VONV
$20.5B
$3.27M 0.12%
40,191
-937
-2% -$78.9K
JNJ icon
74
Johnson & Johnson
JNJ
$641B
$3.23M 0.12%
22,360
-851
-4% -$132K
DLN icon
75
WisdomTree US LargeCap Dividend Fund
DLN
$6.25B
$3.22M 0.12%
41,366
-973
-2% -$77.6K

Similar funds

Aspiriant LLC's Q4 2024 Portfolio in Review

As of Q4 2024, Aspiriant LLC held 311 positions worth $2.77B, up 5.1% from $2.64B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Aspiriant LLC deployed $184M of net new capital in Q4 2024, opening 19 new positions and adding to 124 existing holdings. Its largest new stake was iShares ESG Optimized MSCI USA ETF: 6,868 shares worth $835K.

By sector, the portfolio is most concentrated in Technology at 4.5% of assets, up from 4.5% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Vanguard Dividend Appreciation ETF, an estimated $3.46M trimmed.

  • Aspiriant LLC's largest Q4 2024 buy was iShares ESG Optimized MSCI USA ETF: 6,868 shares worth $835K.
  • Aspiriant LLC added most to Vanguard Small-Cap Value ETF in Q4 2024, an estimated $74.5M increase.
  • Aspiriant LLC's biggest Q4 2024 reduction was Vanguard Dividend Appreciation ETF, cutting an estimated $3.46M.
  • Aspiriant LLC fully exited Robinhood in Q4 2024, selling an estimated $985K.
  • Aspiriant LLC's ten largest holdings make up 67% of its $2.77B portfolio in Q4 2024.
  • Aspiriant LLC opened 19 new positions and closed 23 in Q4 2024.
  • Aspiriant LLC's portfolio value rose 5.1% quarter-over-quarter to $2.77B.

Based on Aspiriant LLC's 13F filing for Q4 2024, filed 16 Jan 2025.